Alleviant Medical, Inc. develops minimally invasive medical devices for treating heart failure, specifically through a no-implant atrial shunt.

FIRE1 is a connected medical device solutions company focused on developing a heart failure management platform that enables patient self-management and reduces healthcare burdens.

Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Purespring Therapeutics is a gene therapy company specializing in developing treatments for kidney diseases using a proprietary adeno-associated viral (AAV) platform.